Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 21, 2014; 20(35): 12588-12594
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12588
Table 2 Sequential changes of laboratory parameters from the baseline levels to the levels at 1, 3, 6, 12 mo after combination therapy
Pre-TACE+RFAAfter TACE+RFA
Liver function parametersBaselineAt 1 moAt 3 moAt 6 moAt 9 moAt 12 mo
ALT (IU/L)44.41 ± 40.4851.52 ± 46.1938.71 ± 28.1638.50 ± 23.8838.05 ± 27.7237.69 ± 20.94
Albumin (g/dL)3.65 ± 0.523.50 ± 0.5113.64 ± 0.503.69 ± 0.483.67 ± 0.503.66 ± 0.48
Bilirubin (mg/dL)1.17 ± 0.691.23 ± 0.801.20 ± 0.691.22 ± 0.761.23 ± 0.731.23 ± 0.79
Prothrombin time (INR)1.21 ± 0.161.22 ± 0.191.20 ± 0.171.20 ± 0.171.20 ± 0.181.20 ± 0.19